Allinky Biopharma

Shaping the future of Medicine

Allinky is a company dedicated to the discovery and development of novel therapeutic agents that block the biochemical signals driving cancer and inflammation. Following Nature's own strategy to block the excess activation of molecular signals, our “allosteric” small molecules switch off the signals responsible for disease onset and progression. In this way, we are capable of more specifically addressing the molecular causes of cancer and inflammation.

Allinky’s founders are renowned scientists and doctors who are driven to discover and develop novel therapeutic agents that benefit those suffering from diseases that are still to receive an adequate clinical response.

Cancer Inflammation Technology Pipeline Leadership News & Contact